15 | Brentuximab VedotinIBA
10/2023
-
01/2012 |
15 | Rituximab (Mabthera)FDA Link
01/2023
-
07/2012 |
12 | Doxorubicin (Adriamycin)FDA LinkGeneric
01/2023
-
12/2013 |
7 | Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2022
-
12/2013 |
6 | Bleomycin (Blenoxane)FDA LinkGeneric
01/2023
-
12/2013 |
6 | Dacarbazine (DIC)FDA LinkGeneric
01/2023
-
04/2014 |
6 | Vincristine (Oncovin)FDA LinkGeneric
10/2022
-
12/2013 |
5 | Vinblastine (Vinblastine Sulfate)FDA Link
01/2023
-
11/2017 |
5 | Prednisone (Sone)FDA LinkGeneric
10/2022
-
12/2013 |
4 | Bortezomib (Velcade)FDA Link
01/2018
-
07/2011 |
3 | Dexamethasone (Maxidex)FDA LinkGeneric
01/2021
-
12/2013 |
3 | LigandsIBA
10/2018
-
09/2016 |
2 | Lenalidomide (CC 5013)FDA Link
01/2023
-
07/2012 |
2 | Etoposide (VP 16)FDA LinkGeneric
12/2018
-
02/2016 |
2 | NivolumabIBA
10/2018
-
09/2016 |
2 | Lipase (Acid Lipase)FDA Link
10/2018
-
09/2016 |
2 | Cytarabine (Cytosar-U)FDA LinkGeneric
01/2018
-
12/2013 |
2 | Melphalan (Alkeran)FDA LinkGeneric
01/2018
-
11/2015 |
2 | Busulfan (Busulfex)FDA Link
01/2018
-
11/2015 |
2 | Methotrexate (Mexate)FDA LinkGeneric
01/2018
-
12/2013 |
2 | GemcitabineFDA Link
01/2018
-
11/2015 |
2 | AntigensIBA
01/2016
-
08/2012 |
2 | VorinostatFDA Link
01/2016
-
11/2015 |
2 | Histone Deacetylase InhibitorsIBA
11/2015
-
12/2011 |
2 | Monoclonal AntibodiesIBA
01/2014
-
01/2014 |
1 | ibrutinibIBA
01/2023 |
1 | carfilzomibIBA
02/2022 |
1 | Mitoxantrone (Novantrone)FDA LinkGeneric
01/2021 |
1 | fludarabineIBA
01/2021 |
1 | ibritumomab tiuxetan (Zevalin)FDA Link
01/2021 |
1 | pembrolizumabIBA
11/2019 |
1 | Thyroxine (Levothyroxine)FDA LinkGeneric
01/2018 |
1 | Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2018 |
1 | B7-H1 AntigenIBA
01/2018 |
1 | IfosfamideFDA LinkGeneric
02/2016 |
1 | Carboplatin (JM8)FDA LinkGeneric
02/2016 |
1 | Azacitidine (5 Azacytidine)FDA Link
01/2016 |
1 | MethyltransferasesIBA
01/2016 |
1 | DNA (Deoxyribonucleic Acid)IBA
01/2016 |
1 | Drug CombinationsIBA
11/2015 |
1 | MK 2206IBA
11/2015 |
1 | AnthracyclinesIBA
03/2015 |
1 | 1-dodecylpyridoxal (PLD)IBA
03/2015 |
1 | R-CHOP protocolIBA
03/2015 |
1 | liposomal doxorubicin (Doxil)FDA Link
03/2015 |
1 | Topotecan (Hycamtin)FDA LinkGeneric
10/2014 |
1 | PlatinumIBA
10/2014 |
1 | Paclitaxel (Taxol)FDA LinkGeneric
10/2014 |
1 | lucatumumabIBA
01/2014 |
1 | Immune Checkpoint InhibitorsIBA
01/2014 |
1 | pidilizumabIBA
01/2014 |
1 | CytokinesIBA
12/2013 |
1 | PanobinostatIBA
12/2013 |
1 | EverolimusFDA Link
12/2013 |
1 | 11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA
11/2012 |
1 | Janus Kinase 2IBA
11/2012 |
1 | Peptides (Polypeptides)IBA
08/2012 |